Aug 16 |
Masimo receives unsolicited offers for audio business
|
Aug 15 |
Accuray's (ARAY) Radixact for Cancer Treatment Debuts in US
|
Aug 15 |
Masimo's (MASI) W1 Watch Gains FDA Nod for SafetyNet Connectivity
|
Aug 15 |
Masimo is Executing a Successful Strategy to Deliver Long-Term, Sustainable Growth
|
Aug 13 |
Masimo Corporation (MASI) Faces a Fierce Battle Against Activist Hedge Fund Politan Capital
|
Aug 13 |
FDA approves Masimo’s medical watch for telemonitoring connectivity
|
Aug 12 |
Masimo gets FDA clearance for W1 medical watch connectivity
|
Aug 12 |
Masimo W1® Medical Watch Receives FDA 510(k) Clearance for Connectivity to the Masimo SafetyNet® Telemonitoring System
|
Aug 8 |
What Makes Masimo (MASI) a New Buy Stock
|
Aug 8 |
Masimo Second Quarter 2024 Earnings: EPS Beats Expectations
|